Oxcarbazepine

Product NDC
50268-680
11-digit product format
502680680
Labeler code
50268
Product ID
50268-680_2b4c161c-f20b-38d5-e063-6394a90a8a79
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Oxcarbazepine
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
AvPAK
Application
ANDA215939
Marketing category
ANDA
Marketing start
2023-06-07
Substance
OXCARBAZEPINE
Active strength
300 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A215939-001OXCARBAZEPINEOXCARBAZEPINE150MGTABLET / ORALAB2022-01-11
A215939-002OXCARBAZEPINEOXCARBAZEPINE300MGTABLET / ORALAB2022-01-11
A215939-003OXCARBAZEPINEOXCARBAZEPINE600MGTABLET / ORALAB2022-01-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A215939-001AB
A215939-002AB
A215939-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 96 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-11011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-11011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-11011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-1131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-1131067a03dcf5…
2025-08-23 18:47 UTC2025-08A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-116a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-116a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-116a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-11fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-11fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-11b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-11b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-11b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-1103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-1103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-1103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-112680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-112680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-112680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-115bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-115bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-115bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-11d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-11d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-11d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-11d06236e962d9…
2024-10-29 15:01 UTC2024-10A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-11d06236e962d9…
2024-10-29 15:01 UTC2024-10A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-11d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-1179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-1179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-1179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-11301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-11301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-11301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-111e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215939-002OXCARBAZEPINE300MGTABLET / ORALAB2022-01-111e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215939-003OXCARBAZEPINE600MGTABLET / ORALAB2022-01-111e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215939-001OXCARBAZEPINE150MGTABLET / ORALAB2022-01-118072bd15b7f6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 96 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A215939-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215939-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A215939-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215939-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215939-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A215939-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A215939-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215939-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A215939-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215939-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215939-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A215939-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215939-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215939-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A215939-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215939-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215939-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A215939-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215939-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215939-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A215939-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215939-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215939-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A215939-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215939-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215939-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A215939-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A215939-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A215939-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A215939-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215939-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215939-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A215939-003AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215939-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215939-002AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A215939-003AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215939-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215939-002AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A215939-003AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A215939-001AB18072bd15b7f6…

Additional Listing Data#

Finished product
Yes
Brand name base
Oxcarbazepine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OXCARBAZEPINE300 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
VZI5B1W380Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
312136Internal RxNorm lookup
312137Internal RxNorm lookup
312138Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
fd8da0e9-d69b-7587-e053-6294a90a33c0Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ca2a6da1-5711-44d0-9e79-c84d4265f98bProduct name320250724
536d5b6b-66f1-478b-2670-88fd15947e3bProduct name720250218

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50268-680-11Oxcarbazepine1 in 1 BLISTER PACKTABLET, FILM COATED12
50268-680-15Oxcarbazepine50 in 1 BOXTABLET, FILM COATED502

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50268-680-11EA - Each50268-680df8b84ea-062f-4d4c-966c-5af2dfc568c812023-07-06
50268-680-15EA - Each50268-680a97703b8-8018-4ee3-a66e-d64a581e5f3d12023-07-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50268-680OXCARBAZEPINE TABLET, FILM COATED [AVPAK]2Current NDC, 2 package rows20250112_fd8da0e9-d69b-7587-e053-6294a90a33c0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 14 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OxcarbazepineOXCARBAZEPINECardinal Health 107, LLC3e0f8d9f-7659-4524-8f93-6200314356c82026-07-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEAmerican Health Packagingc0f9df3f-280e-4394-8d7e-ad04803b26352026-07-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEREMEDYREPACK INC.c7718f8b-63e2-40b9-b519-e687cfc2cacf2026-06-11Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEREMEDYREPACK INC.188a48ad-c412-416a-b15b-de5f232740a22026-06-11Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEREMEDYREPACK INC.0abe9478-4084-286d-e063-6294a90a9ba72026-06-10Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEASCLEMED USA INC.c42b2cb2-8b45-488b-bf63-81909a1f06cb2026-05-19Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINECoupler LLC512ab25c-ea79-1e59-e063-6294a90ae9a02026-05-06Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINENCS HealthCare of KY, LLC dba Vangard Labs3fb47782-3dfc-458c-92a6-493de1207c0e2026-04-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OXCARBAZEPINEOXCARBAZEPINENorthStar RxLLC20d826cd-fa4a-4570-9e10-9d7d10fb725b2026-03-17Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINECamber Pharmaceuticals, Inc.fe49a773-562c-4da6-96b7-bba52f4d61e22026-01-30Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEProficient Rx LP433d9d03-a36e-42c6-8e4d-f333ed60e45a2025-03-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEBryant Ranch Prepack23137a89-cbd0-4a5f-8220-f26b7ba543302025-01-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
OxcarbazepineOXCARBAZEPINEAvPAKfd8da0e9-d69b-7587-e053-6294a90a33c02025-01-09Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939
ndc (product): 50268-680
OxcarbazepineOXCARBAZEPINEXLCare Pharmaceuticals Inc.9f5d17e4-ca68-48e2-9e87-d3ab1c59aa932024-07-16Warnings, Adverse reactionsExact identifier
application applno (ANDA): 215939
application number: ANDA215939

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312136OXcarbazepine 150 MG Oral TabletPSNfd8da0e9-d69b-7587-e053-6294a90a33c02
312137OXcarbazepine 300 MG Oral TabletPSNfd8da0e9-d69b-7587-e053-6294a90a33c02
312138OXcarbazepine 600 MG Oral TabletPSNfd8da0e9-d69b-7587-e053-6294a90a33c02
312136oxcarbazepine 150 MG Oral TabletSCDfd8da0e9-d69b-7587-e053-6294a90a33c02
312137oxcarbazepine 300 MG Oral TabletSCDfd8da0e9-d69b-7587-e053-6294a90a33c02
312138oxcarbazepine 600 MG Oral TabletSCDfd8da0e9-d69b-7587-e053-6294a90a33c02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
50268-680-11502680680111 in 1 BLISTER PACKHistorical
50268-680-155026806801550 BLISTER PACK in 1 BOX (50268-680-15) / 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-680-11) 50 blister pack2023-06-07NoNoCurrent